MustGrow Biologics Corp.
MGROF
$0.7884
-$0.0325-3.96%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -97.55% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -97.55% | -- | -- | -- | -- |
| Cost of Revenue | 61.04% | 17.71% | -71.17% | -17.24% | 417.16% |
| Gross Profit | -100.79% | 359.96% | 71.17% | 17.24% | 25,430.60% |
| SG&A Expenses | -5.83% | 9.95% | -1.45% | -3.01% | -2.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.22% | 9.41% | -24.41% | -5.63% | 15.27% |
| Operating Income | -128.81% | 6.53% | 24.41% | 5.63% | 482.66% |
| Income Before Tax | -134.37% | 11.12% | 21.53% | 0.83% | 441.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -134.37% | 11.12% | 21.53% | 0.83% | 441.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -134.37% | 11.12% | 21.53% | 0.83% | 441.68% |
| EBIT | -128.81% | 6.53% | 24.41% | 5.63% | 482.66% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -133.53% | 14.03% | 24.44% | 4.49% | 436.24% |
| Normalized Basic EPS | -133.55% | 14.37% | 24.11% | 4.12% | 436.56% |
| EPS Diluted | -133.53% | 14.03% | 24.44% | 4.49% | 436.24% |
| Normalized Diluted EPS | -133.55% | 14.37% | 24.11% | 4.12% | 436.56% |
| Average Basic Shares Outstanding | 2.62% | 3.53% | 3.91% | 3.60% | 1.32% |
| Average Diluted Shares Outstanding | 2.62% | 3.53% | 3.91% | 3.60% | 1.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |